neotiv
Alzheimer’s research and patient-centered digital care

About neotiv
Enabling cognitive health
neotiv GmbH develops digital biomarkers for the early detection of neurodegenerative diseases, in particular Alzheimer’s, and integrates them into a user-friendly software platform to support diagnosis and care. The company works closely with academic partners and uses the latest neuroscientific findings.
Management
bmp Ventures Team
Founded
2017
Invested
2021
Stage
Start-up
Industry
Life Sciences & eHealth
Status
Active